Michael Bigham, Executive Chairman of the Board at Paratek Pharmaceuticals, Inc. (PRTK), sold 15,750 shares at $1.99 ($31K) on 2022-12-21, disclosed to the SEC on 2022-12-22.
Scheduled sale ($31k) by Executive Chairman of the Board under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PRTK | SELL | 2022-11-01 | $21K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $152K | — | Filing → |
| PRTK | SELL | 2021-12-15 | $212K | — | Filing → |